Viridian Therapeutics develops targeted therapies for patients with diseases that lack effective treatment options, utilizing advanced drug discovery techniques to identify and optimize novel compounds. The company focuses on addressing the unmet medical needs in specific disease areas, improving patient outcomes through precision medicine.
Funding
$225M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many diseases lack effective treatment options, leaving patients with unmet medical needs. Traditional drug discovery techniques may not always identify and optimize novel compounds effectively for these diseases.
Solution
Viridian Therapeutics is dedicated to creating targeted therapies for patients suffering from diseases where current treatments are inadequate. The company employs advanced drug discovery techniques to pinpoint and refine innovative compounds. By focusing on specific disease areas with significant unmet needs, Viridian aims to enhance patient outcomes through precision medicine. Their approach involves identifying unique molecular targets and developing therapies that selectively interact with these targets to maximize efficacy and minimize side effects.
Target Audience
The primary target audience includes patients with diseases lacking effective treatment options and the healthcare providers who treat them.
Features
- Advanced drug discovery platform for identifying novel therapeutic compounds
- Focus on precision medicine to target specific disease mechanisms
- Development of therapies for diseases with limited or no effective treatment options